Central nervous system (CNS) disorders especially neurodegenerative disorders are the
major challenge for public health and demand the great attention of researchers to protect …

Nanotechnology has been applied in the medicine field to improve the treatment of a wide
range of diseases. However, to reach the nanomedicines delivery to desirable target tissue …

As a progressive, irreversible neurodegenerative disease, Alzheimer's disease (AD)
continues to be a serious public health problem worldwide. Currently, the most available …

The neurological disorders affect millions of people worldwide, and are bracketed as the
foremost basis of disability-adjusted life years (DALYs). The treatment options are …

Neurodegenerative disorders are distinguished by the gradual deterioration of the nervous
system's structure and function due to oxidative stress, mitochondrial dysfunction, protein …

The clinical application of EDV, a potent antioxidant drug approved for amyotrophic lateral
sclerosis (ALS), is limited by its short biological half-life and poor water solubility …

The recent approval of edaravone has provided an intravenous option to treat amyotrophic
lateral sclerosis (ALS) in addition to the existing oral agent, riluzole. The present work was …

Lycopene is considered as a promising neuroprotector with multiple bioactivities, while its
therapeutic use in neurological disorders is restricted due to low solubility, instability and …

Sorafenib (SFB) has improved the treatment of hepatocellular carcinoma (HCC) and has
fewer severe side effects than other agents used for that purpose. However, due to a lack of …

Mole fraction solubilities have been measured for anthracene, benzoic acid, benzoin, 4-tert-
butylbenzoic acid, 1-chloroanthraquinone, 3-chlorobenzoic acid, 4-chlorobenzoic acid, 4 …